DALLAS, November 17, 2011 /PRNewswire/ --
The report "Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast) [http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html]", as the name suggests, analyzes and studies the major market drivers, restraints, and opportunities in North America (U.S. & Canada), Europe (Germany, France, U.K., Italy, and Spain) and emerging markets (Brazil, India, China, Russia, Turkey, and South Korea).
Browse market data tables and in-depth TOC on Prostate Cancer Therapeutics Market (2010-2020) (Opportunity Analysis, Pipeline Assessment and Global Market Forecast).
Early buyers will receive 10% customization on reports.
The prostate is an exocrine gland found in men, located in the groin area just below the bladder and in front of the rectum. In prostate cancer, cells within the gland mutate into cancer cells. Further, these affected cells start killing the other healthy gland cells, and can spread to the other body parts. Prostate cancer is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancerous death in men. Globally, about 899,000 men were diagnosed with prostate cancer in 2008 and it is estimated that this number will get doubled (1.7 million) by 2030.
Global prostate cancer therapeutics market [ http://www.marketsandmarkets.com/Market-Reports/prostate-cance-drugs-market-413.html ] was valued at $2,713 million in 201
Copyright©2010 PR Newswire.
All rights reserved